One of Blood Cancer Research WA’s supporters is the Rachel Doherty Foundation (RDF) which advocates for the establishment of a clinical network for new generation drug trials and cancer research.

“Rachael was diagnosed with Hodgkin’s lymphoma in 2004 and bravely fought the disease for eight years. Just 17 when diagnosed, Rachael was several months short of her 26th birthday when she finally succumbed to pneumonia caused by the effects of cancer. Unfortunately, Rachael’s story is all too typical for Australians – many of them young and vibrant like her – who are ravaged by a disease that knows no bounds”. 

Moving to different hospitals all over Perth for treatment and the lack of access to the newest drugs via clinical trials was a huge hurdle in Rachel’s fight with Hodgkin’s Lymphoma, which saw her having to frequently travel to Melbourne to be able to receive the latest treatments. The Rachel Doherty Foundation are proudly supporting Blood Cancer Research WA.

Blood Cancer Research WA are specialising in the Research of Leukaemia, Lymphoma and Myeloma. Our purpose is to give patients with blood cancers access to new and potentially life-saving treatments, faster:

To read more about Rachel’s story and the work that the RDF do, click here: